Patents by Inventor Rosemay Vazeux
Rosemay Vazeux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20050176020Abstract: DNA sequences encoding a novel human intercellular adhesion molecule polypeptide (designated “ICAM-R”) and variants thereof are disclosed along with methods and materials for production of the same by recombinant procedures. Antibodies substances specific for ICAM-R and variants thereof are also disclosed as useful in both the isolation of ICAM-R from natural cellular sources and the modulation of ligand/receptor binding reactions involving ICAM-R.Type: ApplicationFiled: May 18, 2004Publication date: August 11, 2005Inventors: W. Gallatin, Rosemay Vazeux
-
Publication number: 20040248211Abstract: DNA sequences encoding a novel human intercellular adhesion molecule polypeptide (designated “ICAM-R”) and variants thereof are disclosed along with methods and materials for production of the same by recombinant procedures. Binding molecules specific for ICAM-R and variants thereof are also disclosed as useful in both the isolation of ICAM-R from natural cellular sources and the modulation of ligand/receptor binding biological activities of ICAM-R.Type: ApplicationFiled: July 28, 2004Publication date: December 9, 2004Inventors: Michael Gallatin, Rosemay Vazeux
-
Patent number: 6818743Abstract: DNA sequences encoding a novel human intercellular adhesion molecule polypeptide (designated “ICAM-R”) and variants thereof are disclosed along with methods and materials for production of the same by recombinant procedures. Antibodies substances specific for ICAM-R and variants thereof are also disclosed as useful in both the isolation of ICAM-R from natural cellular sources and the modulation of ligand/receptor binding reactions involving ICAM-R.Type: GrantFiled: September 28, 1994Date of Patent: November 16, 2004Assignee: ICOS CorporationInventors: W. Michael Gallatin, Rosemay Vazeux
-
Publication number: 20030199423Abstract: DNA sequences encoding a novel human intercellular adhesion molecule polypeptide (designated “ICAM-R”) and variants thereof are disclosed along with methods and materials for production of the same by recombinant procedures. Binding molecules specific for ICAM-R and variants thereof are also disclosed as useful in both the isolation of ICAM-R from natural cellular sources and the modulation of ligand/receptor binding biological activities of ICAM-R.Type: ApplicationFiled: June 5, 2002Publication date: October 23, 2003Inventors: W. Michael Gallatin, Rosemay Vazeux
-
Publication number: 20010029293Abstract: DNA sequences encoding a novel human intercellular adhesion molecule polypeptide (designated “ICAM-R”) and variants thereof are disclosed along with methods and materials for production of the same by recombinant procedures. Binding molecules specific for ICAM-R and variants thereof are also disclosed as useful in both the isolation of ICAM-R from natural cellular sources and the modulation of ligand/receptor binding biological activities of ICAM-R.Type: ApplicationFiled: January 3, 2001Publication date: October 11, 2001Applicant: ICOS CorporationInventors: W. Michael Gallatin, Rosemay Vazeux
-
Patent number: 6153395Abstract: DNA sequences encoding a novel human intercellular adhesion molecule polypeptide (designated "ICAM-R") and variants thereof are disclosed along with methods and materials for production of the same by recombinant procedures. Binding molecules specific for ICAM-R and variants thereof are also disclosed as useful in both the isolation of ICAM-R from natural cellular sources and the modulation of ligand/receptor binding biological activities of ICAM-R.Type: GrantFiled: August 26, 1994Date of Patent: November 28, 2000Assignee: ICOS CorporationInventors: W. Michael Gallatin, Rosemay Vazeux
-
Patent number: 6100383Abstract: DNA sequences encoding a novel human intercellular adhesion molecule polypeptide (designated "ICAM-R") and variants thereof are disclosed along with methods and materials for production of the same by recombinant procedures. Binding molecules specific for ICAM-R and variants thereof are also disclosed as useful in both the isolation of ICAM-R from natural cellular sources and the modulation of ligand/receptor binding biological activities of ICAM-R.Type: GrantFiled: June 7, 1995Date of Patent: August 8, 2000Assignee: ICOS CorporationInventors: W. Michael Gallatin, Rosemay Vazeux
-
Patent number: 6087130Abstract: Antibody substances that bind to a novel human intercellular adhesion molecule polypeptide (designated "ICAM-R") and variants thereof are disclosed along with methods and materials producing and screening the same for desired functional and binding properties. Binding molecules specific for ICAM-R and variants thereof are also disclosed as useful in both the isolation of ICAM-R from natural cellular sources and the modulation of ligand/receptor binding biological activities of ICAM-R.Type: GrantFiled: May 27, 1997Date of Patent: July 11, 2000Inventors: W. Michael Gallatin, Rosemay Vazeux
-
Patent number: 6040176Abstract: DNA sequences encoding a novel human intercellular adhesion molecule polypeptide (designated "ICAM-R") and variants thereof are disclosed along with methods and materials for production of the same by recombinant procedures. Antibodies and other binding molecules specific for ICAM-R and variants thereof are also disclosed as useful in both the isolation of ICAM-R from natural cellular sources and the modulation of ligand/receptor binding biological activities of ICAM-R.Type: GrantFiled: September 12, 1996Date of Patent: March 21, 2000Assignee: ICOS CorporationInventors: W. Michael Gallatin, Rosemay Vazeux
-
Patent number: 5989843Abstract: Modulators of protein kinase C phosphorylation of human intercellular adhesion molecule polypeptide (designated "ICAM-R") are identified through novel methods.Type: GrantFiled: September 27, 1996Date of Patent: November 23, 1999Assignee: ICOS CorporationInventors: W. Michael Gallatin, Rosemay Vazeux
-
Patent number: 5880268Abstract: DNA sequences encoding a novel human intercellular adhesion molecule polypeptide (designated "ICAM-R") and variants thereof are disclosed along with methods and materials for production of the same by recombinant procedures. Binding molecules specific for ICAM-R and variants thereof are also disclosed as useful in both the isolation of ICAM-R from natural cellular sources and the modulation of ligand/receptor binding biological activities of ICAM-R. Specifically, antibody substances which modulate the interaction between ICAM-R and ad/CD18 are provided.Type: GrantFiled: June 7, 1995Date of Patent: March 9, 1999Assignee: ICOS CorporationInventors: W. Michael Gallatin, Rosemay Vazeux
-
Patent number: 5869262Abstract: Methods for monitoring the progression of systemic lupus erythematosus (SLE) in a patient by detecting elevated levels of circulating ICAM-R wherein progression is indicated in an SLE patient whose circulating ICAM-R levels are increased as compared to normal individuals or individuals with in active SLE. Methods for the detection of an inflammatory disease state selected from the group consisting of rheumatoid arthritis, SLE, and Guillain-Barre syndrome and multiple sclerosis in a patient by detecting elevated levels of circulating ICAM-R wherein the presence of the inflammatory disease state is indicated in a patient whose circulating ICAM-R levels are increased as compared to normal healthy individuals. ICAM-R is also known as ICAM-3 and CDw50 in the art.Type: GrantFiled: June 7, 1995Date of Patent: February 9, 1999Assignee: ICOS CorporationInventors: W. Michael Gallatin, Rosemay Vazeux
-
Patent number: 5837822Abstract: DNA sequences encoding a novel human intercellular adhesion molecule polypeptide (designated "ICAM-R") and variants thereof are disclosed along with methods and materials for production of the same by recombinant procedures. Binding molecules specific for ICAM-R and variants thereof are also disclosed as useful in both the isolation of ICAM-R from natural cellular sources and the modulation of ligand/receptor binding biological activities of ICAM-R. More specifically, humanized antibodies specific for ICAM-R proteins are disclosed.Type: GrantFiled: June 7, 1995Date of Patent: November 17, 1998Assignee: ICOS CorporationInventors: W. Michael Gallatin, Rosemay Vazeux
-
Patent number: 5811517Abstract: DNA sequences encoding a novel human intercellular adhesion molecule polypeptide (designated "ICAM-R") and variants thereof are disclosed along with methods and materials for production of the same by recombinant procedures. Binding molecules specific for ICAM-R and variants thereof are also disclosed as useful in both the isolation of ICAM-R from natural cellular sources and the modulation of ligand/receptor binding biological activities of ICAM-R.Type: GrantFiled: June 7, 1995Date of Patent: September 22, 1998Assignee: ICOS CorporationInventors: W. Michael Gallatin, Rosemay Vazeux
-
Patent number: 5773218Abstract: DNA sequences encoding a novel human intercellular adhesion molecule polypeptide (designated "ICAM-R") and variants thereof are disclosed along with methods and materials for production of the same by recombinant procedures. Binding molecules specific for ICAM-R and variants thereof are also disclosed as useful in both the isolation of ICAM-R from natural cellular sources and the modulation of ligand/receptor binding biological activities of ICAM-R.Type: GrantFiled: June 7, 1995Date of Patent: June 30, 1998Assignee: ICOS CorporationInventors: W. Michael Gallatin, Rosemay Vazeux
-
Patent number: 5770686Abstract: DNA sequences encoding a novel human intercellular adhesion molecule polypeptide (designated "ICAM-R") and variants thereof are disclosed along with methods and materials for production of the same by recombinant procedures. Binding molecules specific for ICAM-R and variants thereof are also disclosed as useful in both the isolation of ICAM-R from natural cellular sources and the modulation of ligand/receptor binding biological activities of ICAM-R.Type: GrantFiled: June 7, 1995Date of Patent: June 23, 1998Assignee: ICOS CorporationInventors: W. Michael Gallatin, Rosemay Vazeux
-
Patent number: 5663293Abstract: DNA sequences encoding a novel human intercellular adhesion molecule polypeptide (designated "ICAM-R") and variants thereof are disclosed along with methods and materials for production of the same by recombinant procedures. Binding molecules specific for ICAM-R and variants thereof are also disclosed as useful in both the isolation of ICAM-R from natural cellular sources and the modulation of ligand/receptor binding biological activities of ICAM-R.Type: GrantFiled: May 3, 1995Date of Patent: September 2, 1997Assignee: ICOS CorporationInventors: W. Michael Gallatin, Rosemay Vazeux
-
Patent number: 5532127Abstract: DNA sequences encoding a novel human intercellular adhesion molecule polypeptide (designated "ICAM-R") and variants thereof are disclosed along with methods and materials for production of the same by recombinant procedures. Antibodies substances specific for ICAM-R and variants thereof are also disclosed as useful in both the isolation of ICAM-R from natural cellular sources and the modulation of ligand/receptor binding reactions involving ICAM-R.Type: GrantFiled: September 28, 1994Date of Patent: July 2, 1996Assignee: ICOS CorporationInventors: W. Michael Gallatin, Rosemay Vazeux
-
Patent number: 5525487Abstract: DNA sequences encoding a novel human intercellular adhesion molecule polypeptide (designated "ICAM-R") and variants thereof are disclosed along with methods and materials for production of the same by recombinant procedures. Antibodies substances specific for ICAM-R and variants thereof are also disclosed as useful in both the isolation of ICAM-R from natural cellular sources and the inhibition of ligand/receptor binding reactions involving ICAM-R.Type: GrantFiled: September 28, 1994Date of Patent: June 11, 1996Assignee: ICOS CorporationInventors: W. Michael Gallatin, Rosemay Vazeux